For: | Rajab AAH, Hegazy WAH. What’s old is new again: Insights into diabetic foot microbiome. World J Diabetes 2023; 14(6): 680-704 [PMID: 37383589 DOI: 10.4239/wjd.v14.i6.680] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/680.htm |
Number | Citing Articles |
1 |
Xiucai Li, Song Wen, Meiyuan Dong, Yue Yuan, Min Gong, Congcong Wang, Xinlu Yuan, Jianlan Jin, Mingyue Zhou, Ligang Zhou. The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot. Diabetes, Metabolic Syndrome and Obesity 2023; : 3197 doi: 10.2147/DMSO.S430426
|
2 |
Ameni Arfaoui, Sandra Martínez-Álvarez, Idris Nasir Abdullahi, Meha Fethi, Noureddine Sayem, Salma Ben Khelifa Melki, Hadda-Imene Ouzari, Carmen Torres, Naouel Klibi. Surveillance of Enterobacteriaceae from Diabetic Foot Infections in a Tunisian Hospital: Detection of E. coli-ST131-blaCTX-M-15 and K. pneumoniae-ST1-blaNDM-1 Strains. Microbial Drug Resistance 2024; 30(8): 341 doi: 10.1089/mdr.2023.0335
|
3 |
Shaimaa I. Nazeih, Mohamed A. M. Ali, Alyaa S. Abdel Halim, Hanan Al-Lawati, Hisham A. Abbas, Mohammed Al-Zharani, Fehmi Boufahja, Mashael A. Alghamdi, Wael A. H. Hegazy, Noura M. Seleem. Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against Pseudomonas aeruginosa and Serratia marcescens: Insights from Molecular and In Vivo Investigations. Microorganisms 2023; 11(10): 2420 doi: 10.3390/microorganisms11102420
|
4 |
Wesam H. Abdulaal, Nabil A. Alhakamy, Amer H. Asseri, Mohamed F. Radwan, Tarek S. Ibrahim, Solomon Z. Okbazghi, Hisham A. Abbas, Basem Mansour, Aly A. Shoun, Wael A. H. Hegazy, Mahmoud Saad Abdel-Halim. Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1366459
|
5 |
Abdulrahman E. Koshak, Mahmoud A. Elfaky, Dina A. I. Albadawi, Hossam M. Abdallah, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Abdulrahim A. Alzain, El-Sayed Khafagy, Eslam M. Elsayed, Wael A. H. Hegazy. Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogens. International Microbiology 2024; doi: 10.1007/s10123-024-00532-8
|
6 |
Shaimaa M. Badr-Eldin, Hibah Mubarak Aldawsari, Osama A. A. Ahmed, Sabna Kotta, Walaa Abualsunun, Bayan A. Eshmawi, El-Sayed Khafagy, Samar S. Elbaramawi, Hisham A. Abbas, Wael A. H. Hegazy, Noura M. Seleem. Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa
. Nanotechnology Reviews 2024; 13(1) doi: 10.1515/ntrev-2023-0212
|
7 |
Mohamed Chakkour, Zeinab Hammoud, Solay Farhat, Ali El Roz, Zeinab Ezzeddine, Ghassan Ghssein. Overview of Proteus mirabilis pathogenicity and virulence. Insights into the role of metals. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1383618
|
8 |
Mohammed W. Al-Rabia, Hani Z. Asfour, Nabil A. Alhakamy, Mohammed A. Bazuhair, Tarek S. Ibrahim, Hisham A. Abbas, Basem Mansour, Wael A. H. Hegazy, Noura M. Seleem. Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing. AMB Express 2024; 14(1) doi: 10.1186/s13568-024-01740-1
|
9 |
Mahmoud M. Bendary, Mohamed A. M. Ali, Alyaa S. Abdel Halim, Fehmi Boufahja, Anis Ahmad Chaudhary, Amr Elkelish, Rania H. M. Soliman, Wael A. H. Hegazy. Investigating Sulforaphane’s anti-virulence and anti-quorum sensing properties against Pseudomonas aeruginosa. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1406653
|
10 |
Humam Rajha, Raneem Alsheikh, Amna Zar, Sara Mohsen, Susu M. Zughaier. Diabetic Foot Ulcers - Pathogenesis, Innovative Treatments and AI Applications. 2024; doi: 10.5772/intechopen.1004761
|
11 |
Mohammed W. Al-Rabia, Hani Z. Asfour, Nabil A. Alhakamy, Wesam H. Abdulaal, Tarek S. Ibrahim, Hisham A. Abbas, Ibrahim M. Salem, Wael A. H. Hegazy, Shaimaa I. Nazeih. Thymoquinone is a natural antibiofilm and pathogenicity attenuating agent in Pseudomonas aeruginosa. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1382289
|
12 |
Mahmoud A. Elfaky, Abdulrahman E. Koshak, Mohamed F. Radwan, Hossam M. Abdallah, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Abdulrahim A. Alzain, Azza A. H. Rajab, Wael A. H. Hegazy. Honokiol from Magnolia Tree Exhibits Antibacterial and Anti-virulence Potential against Pseudomonas aeruginosa. Arabian Journal for Science and Engineering 2024; doi: 10.1007/s13369-024-09303-z
|
13 |
Sheng‐Jie Shiue, Ming‐Shun Wu, Yi‐Hsien Chiang, Hsin‐Yi Lin. Bacteriophage‐cocktail hydrogel dressing to prevent multiple bacterial infections and heal diabetic ulcers in mice. Journal of Biomedical Materials Research Part A 2024; doi: 10.1002/jbm.a.37728
|
14 |
Hadil Faris Alotaibi, Haifa Alotaibi, Khaled M. Darwish, El-Sayed Khafagy, Amr S. Abu Lila, Mohamed A. M. Ali, Wael A. H. Hegazy, Samar Zuhair Alshawwa. The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens. Biomedicines 2023; 11(12): 3161 doi: 10.3390/biomedicines11123161
|
15 |
Salwa E. Gomaa, Hisham A. Abbas, Fatma A. Mohamed, Mohamed A. M. Ali, Tarek M. Ibrahim, Alyaa S. Abdel Halim, Mashael A. Alghamdi, Basem Mansour, Anis Ahmad Chaudhary, Amr Elkelish, Fehmi Boufahja, Wael A. H. Hegazy, Fatma Al-zahraa A. Yehia. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03181-z
|
16 |
Eman I. El-Kimary, Eslam K. Fahmy, Safya E. Esmaeel, Hany A. Elkattawy, Wael A.H. Hegazy. A review on recent analytical methodologies developed for the micro-determination of piperacillin in different matrices. Microchemical Journal 2024; 205: 111203 doi: 10.1016/j.microc.2024.111203
|